South African rand holds firm after first rate cut in four years

Reuters

South African rand holds firm after first rate cut in four years

2024 9월 19, 오후 4:30 GMT

<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 1-South African rand holds firm after first rate cut in four years</title></head><body>

Updates prices to reflect afternoon trade

By Tannur Anders and Bhargav Acharya

JOHANNESBURG, Sept 19 (Reuters) -The South African rand held onto early gains on Thursday following the South African Reserve Bank's (SARB) decision to cut interest rates for the first time in over four years, after a super-sized interest rate cut by the U.S. Federal Reserve.

At 1600 GMT, the rand traded at 17.4775 against the dollar ZAR=D3, about 0.4% stronger than its previous close.

The U.S. currency =USD was down 0.3% against a basket of peers.

The SARB joined the easing club with a 25 basis point (bps) rate cut ZAREPO=ECI, as predicted by economists polled by Reuters, but struck a measured tone, saying although inflation had fallen faster than expected there were still risks to the outlook.

Data showed on Wednesday that South Africa's annual inflation rate fell to 4.4% last month, lowest since April 2021 and just below the mid-point of the central bank's 3% to 6% target range.

"The rand traded stronger for the seventh consecutive day, trading as low as 17.39 at one point, but ran out of steam in the latter part of the day," said Wichard Cilliers, head of market risk at TreasuryONE, following the rate decision.

The rand's 17.39 per dollar level on Thursday was its strongest since February 2023.

The Fed cut interest rates by 50 bps on Wednesday, weakening the dollar and boosting the risk-sensitive rand.

On the Johannesburg Stock Exchange, the Top-40 index .JTOPI closed about 1.3% higher.

South Africa's benchmark 2030 government bond ZAR2030= was up marginally, with the yield down 1 basis point at 8.84%.

Editing by Alexander Winning, Barbara Lewis and Jane Merriman

</body></html>

South African rand holds firm after first rate cut in four years

관련 자산

최신 뉴스

Travere Therapeutics falls on pausing enrollment in trial for inherited disorder drug

Cassava charged by US SEC for misleading Alzheimer's drug trial claims, shares fall

New Zealand consumer confidence rises in Sept to highest in nearly 3 years

Roaring Chinese stocks set for best week in a decade

MidWestOne Financial falls after launching $100 mln stock offering

XM 실시간 채팅